Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benoit Guillet

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
British Journal of Haematology|September 29, 2022
Biological, clinical features and modelling of heterozygous variants of glycoprotein Ib platelet subunit alpha (GP1BA) and glycoprotein Ib platelet subunit beta (GP1BB) genes responsible for constitutional thrombocytopeniaFatema Dib, Agnès Quéméner, Sophie Bayart, et al.
European Journal of Haematology|February 7, 2023
Management of rare inherited bleeding disorders: Proposals of the French Reference Centre on Haemophilia and Rare Coagulation DisordersMarc Trossaert, Valerie Chamouard, Christine Biron-Andreani, et al.
British Journal of Haematology|October 20, 2018
Bleeding risk for patients with haemophilia under antithrombotic therapy. Results of the French multicentric study ERHEAAlexandre Desjonqueres, Benoit Guillet, Philippe Beurrier, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 24, 2022
Prostate biopsy and prostate cancer management in patients with haemophilia: The experience of French Haemophilia Treatment CentresPhilippe Gautier, Benoit Guillet, Marianne Sigaud, et al.
Thrombosis and Haemostasis|February 9, 2023
A French Real-World Evidence Study Evaluating the Efficacy, Safety, and Pharmacokinetic Parameters of rVIII-SingleChain in Patients with Hemophilia A Receiving ProphylaxisBenoit Guillet, Abel Hassoun, Bénédicte Wibaut, et al.
Haematologica|May 30, 2013
Development of inhibitory antibodies to therapeutic factor VIII in severe hemophilia A is associated with microsatellite polymorphisms in the HMOX1 promoterYohann Repessé, Ivan Peyron, Jordan D Dimitrov, et al.
European Journal of Haematology|December 5, 2024
ORPHEE: A Real-World Study on rIX-FP Prophylaxis Use in Adolescent/Adult Patients With Hemophilia BFabienne Volot, Sabine Castet, Alexandra Fournel, et al.
Research and Practice in Thrombosis and Haemostasis|October 23, 2023
Surgery in rare bleeding disorders: the prospective MARACHI studyFlorence Rousseau, Benoit Guillet, Thibault Mura, et al.
European Journal of Haematology|July 13, 2023
Simoctocog alfa (Nuwiq®) in previously untreated patients with severe haemophilia A-Final efficacy and safety results from the NuProtect studyMary Mathias, Aby Abraham, Mark J Belletrutti, et al.
Thrombosis and Haemostasis|February 13, 2021
Simoctocog Alfa (Nuwiq) in Previously Untreated Patients with Severe Haemophilia A: Final Results of the NuProtect StudyRi J Liesner, Aby Abraham, Carmen Altisent, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
British Journal of Haematology|September 29, 2022
Biological, clinical features and modelling of heterozygous variants of glycoprotein Ib platelet subunit alpha (GP1BA) and glycoprotein Ib platelet subunit beta (GP1BB) genes responsible for constitutional thrombocytopeniaFatema Dib, Agnès Quéméner, Sophie Bayart, et al.
European Journal of Haematology|February 7, 2023
Management of rare inherited bleeding disorders: Proposals of the French Reference Centre on Haemophilia and Rare Coagulation DisordersMarc Trossaert, Valerie Chamouard, Christine Biron-Andreani, et al.
British Journal of Haematology|October 20, 2018
Bleeding risk for patients with haemophilia under antithrombotic therapy. Results of the French multicentric study ERHEAAlexandre Desjonqueres, Benoit Guillet, Philippe Beurrier, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 24, 2022
Prostate biopsy and prostate cancer management in patients with haemophilia: The experience of French Haemophilia Treatment CentresPhilippe Gautier, Benoit Guillet, Marianne Sigaud, et al.
Thrombosis and Haemostasis|February 9, 2023
A French Real-World Evidence Study Evaluating the Efficacy, Safety, and Pharmacokinetic Parameters of rVIII-SingleChain in Patients with Hemophilia A Receiving ProphylaxisBenoit Guillet, Abel Hassoun, Bénédicte Wibaut, et al.
Haematologica|May 30, 2013
Development of inhibitory antibodies to therapeutic factor VIII in severe hemophilia A is associated with microsatellite polymorphisms in the HMOX1 promoterYohann Repessé, Ivan Peyron, Jordan D Dimitrov, et al.
European Journal of Haematology|December 5, 2024
ORPHEE: A Real-World Study on rIX-FP Prophylaxis Use in Adolescent/Adult Patients With Hemophilia BFabienne Volot, Sabine Castet, Alexandra Fournel, et al.
Research and Practice in Thrombosis and Haemostasis|October 23, 2023
Surgery in rare bleeding disorders: the prospective MARACHI studyFlorence Rousseau, Benoit Guillet, Thibault Mura, et al.
European Journal of Haematology|July 13, 2023
Simoctocog alfa (Nuwiq®) in previously untreated patients with severe haemophilia A-Final efficacy and safety results from the NuProtect studyMary Mathias, Aby Abraham, Mark J Belletrutti, et al.
Thrombosis and Haemostasis|February 13, 2021
Simoctocog Alfa (Nuwiq) in Previously Untreated Patients with Severe Haemophilia A: Final Results of the NuProtect StudyRi J Liesner, Aby Abraham, Carmen Altisent, et al.
Pageof 2